Simazin 500 SC Suspensionskoncentrat Danmark - dansk - SEGES Landbrug & Fødevarer

simazin 500 sc suspensionskoncentrat

makhteshim-agan holland b.v. - simazin - suspensionskoncentrat - 500 g/l simazin

Inter-Simazin Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

inter-simazin flydende middel

inter-trade a/s - simazin - flydende middel - 500 g/l simazin

IT-Simazin Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

it-simazin flydende middel

inter-trade agro a/s - simazin - flydende middel - 500 g/l simazin

PLK-Simazin 50 Fl Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

plk-simazin 50 fl flydende middel

klarsø a/s - simazin - flydende middel - 500 g/l simazin

Simazin 50 Flydende Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

simazin 50 flydende flydende middel

dla agro a.m.b.a. - simazin - flydende middel - 500 g/l simazin

DLG Simazin Pulver Danmark - dansk - SEGES Landbrug & Fødevarer

dlg simazin pulver

manglende oplysninger - simazin - pulver - 500 g/l simazin

Gesatop 500 FW Flydende middel Danmark - dansk - SEGES Landbrug & Fødevarer

gesatop 500 fw flydende middel

novartis agri a/s - simazin - flydende middel - 500 g/l simazin

Rinvoq Den Europæiske Union - dansk - EMA (European Medicines Agency)

rinvoq

abbvie deutschland gmbh & co. kg - upadacitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Mogeton Vanddispergerbart pulver Danmark - dansk - SEGES Landbrug & Fødevarer

mogeton vanddispergerbart pulver

cheminova deutschland gmbh & co. kg - quinoclamin - vanddispergerbart pulver - 250 g/kg quinoclamin